During the past decade, JBN Medical Diagnostic Services Inc. conducted 6 clinical trials. In the 10-year time frame, 6 clinical trials started and 9 clinical trials were completed, i.e. on average, 150% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 7 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "JBN Medical Diagnostic Services Inc." #1 sponsor was "Boehringer Ingelheim" with 3 trials, followed by "Genentech, Inc." with 2 trials sponsored, "Hoffmann-La Roche" with 2 trials sponsored, "Pfizer" with 2 trials sponsored and "Allergy Therapeutics" with 2 trials sponsored. Other sponsors include -2 different institutions and companies that sponsored additional 8 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "JBN Medical Diagnostic Services Inc." #1 collaborator was "Eli Lilly and Company" with 3 trials as a collaborator, "Brigham and Women's Hospital" with 1 trials as a collaborator and "Thrombolysis In Myocardial Infarction (TIMI) Academic Research Organization" with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were collaborators in the rest 3 trials.

According to Clinical.Site data, the most researched conditions in "JBN Medical Diagnostic Services Inc." are "Alzheimer's Disease" (5 trials), "Cardiovascular Disease" (3 trials), "Heart Failure" (2 trials), "Diabetes Mellitus, Type 2" (1 trials) and "Dyslipidemia" (1 trials). Many other conditions were trialed in "JBN Medical Diagnostic Services Inc." in a lesser frequency.

Most popular intervention types in "JBN Medical Diagnostic Services Inc." are "Drug" (12 trials) and "Biological" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (10 trials), "Empagliflozin" (2 trials), "bococizumab (PF-04950615)" (2 trials), "Aducanumab (BIIB037)" (1 trials) and "Crenezumab" (1 trials). Other intervention names were less common.

The vast majority of trials in "JBN Medical Diagnostic Services Inc." are 13 trials for "All" genders.

Currently, there are NaN active trials in "JBN Medical Diagnostic Services Inc.". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 9 completed trials in JBN Medical Diagnostic Services Inc., undefined suspended trials, and 4 terminated clinical trials to date.

Out of the total trials that were conducted in JBN Medical Diagnostic Services Inc., 0 "Phase 1" clinical trials were conducted, 3 "Phase 2" clinical trials and 8 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 2 trials, and there were also 0 trials that are defined as “Not Applicable".